Glaxosmithkline Hires Goldman Sachs Banker as new Chief Financial Officer

Glaxosmithkline said on Wednesday it had hired Goldman Sachs investment banker Simon Dingemans to succeed Chief Financial Officer Julian Heslop, 59, who will retire next March.

Dingemans has more than 25 years experience in investment banking and most recently led Goldman Sachs' european M&A business, Britain's largest drugmaker said.

Chief Executive Andrew Witty said the appointment reflected the need for Glaxosmithkline to operate with both creativity and continued financial discipline. "Simon will bring valuable experience and capability to support us in our strategy to grow and diversify GSK's business through organic means and bolt-on acquisitions," he said.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.